Jane Street’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-10,200
| Closed | -$276K | – | 10655 |
|
|
2024
Q2 | $276K | Sell |
10,200
-701,000
| -99% | -$14.6M | ﹤0.01% | 7930 |
|
|
2024
Q1 | $13M | Buy |
711,200
+698,200
| +5,371% | +$11.1M | ﹤0.01% | 1557 |
|
|
2023
Q4 | $160K | Sell |
13,000
-5,600
| -30% | -$52.5K | ﹤0.01% | 8362 |
|
|
2023
Q3 | $279K | Buy |
+18,600
| New | +$387K | ﹤0.01% | 7170 |
|
|
2023
Q2 | – | Sell |
-27,200
| Closed | -$1.06M | – | 9783 |
|
|
2023
Q1 | $1.06M | Buy |
+27,200
| New | +$1.33M | ﹤0.01% | 4882 |
|
|
2022
Q4 | – | Sell |
-215,100
| Closed | -$9.68M | – | 10371 |
|
|
2022
Q3 | $9.68M | Buy |
215,100
+179,400
| +503% | +$7.72M | ﹤0.01% | 1729 |
|
|
2022
Q2 | $1.3M | Buy |
35,700
+26,300
| +280% | +$955K | ﹤0.01% | 4993 |
|
|
2022
Q1 | $388K | Sell |
9,400
-30,800
| -77% | -$1.08M | ﹤0.01% | 7935 |
|
|
2021
Q4 | $1.71M | Sell |
40,200
-21,500
| -35% | -$1.08M | ﹤0.01% | 4793 |
|
|
2021
Q3 | $3.4M | Buy |
61,700
+39,900
| +183% | +$2.09M | ﹤0.01% | 3424 |
|
|
2021
Q2 | $1.04M | Buy |
+21,800
| New | +$1.11M | ﹤0.01% | 5746 |
|
|
2020
Q3 | – | Sell |
-7,500
| Closed | -$314K | – | 8104 |
|
|
2020
Q2 | $314K | Buy |
+7,500
| New | +$288K | ﹤0.01% | 5765 |
|
Other funds holding SILK
Jane Street's SILK Position: Q3 2024 in Review
Jane Street sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 115,704 shares — an estimated $3.13M sold.
Jane Street first reported a position in SILK in Q2 2019 and held it in 12 quarters. The position peaked at $4.74M in Q4 2022. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.
- Jane Street reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
- Jane Street sold 115,704 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $3.13M.
- Jane Street first reported a position in Silk Road Medical, Inc. Common Stock in Q2 2019 and held it in 12 quarters.
- Jane Street's Silk Road Medical, Inc. Common Stock position peaked at $4.74M in Q4 2022.
- 1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.
Based on Jane Street's 13F filing for Q3 2024, filed 15 Nov 2024.